Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7016)
All Articles published online
|
Publishing Process of This Article
|
Jan 6, 2024 (publication date) through Apr 22, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Song Z, Zhou Q, Zhang JL, Ouyang J, Zhang ZY. Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts. World J Clin Cases 2024; 12(1): 32-41 [PMID: 38292624 DOI: 10.12998/wjcc.v12.i1.32] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Song Z, Zhou Q, Zhang JL, Ouyang J, Zhang ZY. Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts. World J Clin Cases 2024; 12(1): 32-41 [PMID: 38292624 DOI: 10.12998/wjcc.v12.i1.32] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i1/32.htm |
| Number | Citing Articles |
| 1 |
Anna‐Lena Lemster, Sarah Grünhagen, Sarah Schmalfeld, Florian Lenz, Anna Natzius, Anne Offermann, Sven Perner, Jiong Zhang, Verena Sailer, Jutta Kirfel. Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer. The Prostate 2025; 85(12): 1121 doi: 10.1002/pros.24925
|
| 2 |
Grażyna Gromadzka, Maria Bendykowska. Intermittent Fasting and Androgen Receptor Signaling in Prostate Cancer: Metabolic Crosstalk and Therapeutic Implications. International Journal of Molecular Sciences 2026; 27(6): 2652 doi: 10.3390/ijms27062652
|
| 3 |
Zhen Song, Qi Zhou, Jiang-Lei Zhang, Jun Ouyang, Zhi-Yu Zhang. Correction to: Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts. World Journal of Clinical Cases 2024; 12(36): 6950-6951 doi: 10.12998/wjcc.v12.i36.6950
|
| 4 |
Shristi Modanwal, Viswajit Mulpuru, Ashutosh Mishra, Nidhi Mishra. Transcriptomic signatures of prostate cancer progression: a comprehensive RNA-seq study. 3 Biotech 2025; 15(5) doi: 10.1007/s13205-025-04297-3
|
| 5 |
Liu Xiao, Yuhao Li, Yikai Xing, Lin Li. Value of integrated PET-IVIM MRI in predicting Ki-67 expression in newly diagnosed prostate cancer. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-02467-0
|
| 6 |
Qingchang Ren, Jialong Gu, Nankang Lu. Development and validation of a combined diagnostic model for prostate cancer integrating MRI parameters with p504s, CK5/6, and Ki-67 expression. Open Life Sciences 2026; 21(1) doi: 10.1515/biol-2025-1244
|
| 7 |
Al-Hassan T. Waly, Abed H. Baraaj. <b>The Indispensable Role of Immunohistochemistry in Differentiating Prostate Cancer from Benign Prostatic Hyperplasia</b>. Journal of the Faculty of Medicine Baghdad 2025; 67(4): 464 doi: 10.32007/jfacmedbaghdad3185
|
| 8 |
Li Yan, Pengxiao Su, Xiaoke Sun. Role of multi‑omics in advancing the understanding and treatment of prostate cancer (Review). Molecular Medicine Reports 2025; 31(5): 1 doi: 10.3892/mmr.2025.13495
|
| 9 |
Desheng Zhu, Shiyong Huang. Construction and validation of a lysine beta hydroxybutyrylation related molecular model for predicting biochemical recurrence of prostate cancer. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-12314-x
|
| 10 |
Ana Marta Ferreira, Roberto Jarimba, André Rego, João Gama, Rui Almeida, Miguel Eliseu, Vasco Quaresma, Pedro Nunes, Vitor Sousa, Arnaldo Figueiredo. Prognostic value of Ki67 and PSA-immunostaining in <i>de novo</i> metastatic hormone-sensitive prostate cancer. Archivio Italiano di Urologia e Andrologia 2026; 98(1) doi: 10.4081/aiua.2026.14731
|
| 11 |
Krzysztof Lubiński, Wojciech Marciniak, Róża Derkacz, Adam Kiljańczyk, Milena Kiljańczyk, Marcin R. Lener, Sandra Pietrzak, Cezary Cybulski, Tadeusz Dębniak, Tomasz Huzarski, Wojciech Kluźniak, Tadeusz Sulikowski, Jan Lubiński, Rodney J. Scott, Jacek Gronwald. Evidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk: MKI67 rs11016073 and APOB rs1367117 in a Female Prospective Cohort. International Journal of Molecular Sciences 2026; 27(5): 2317 doi: 10.3390/ijms27052317
|